Atria Investments Inc trimmed its holdings in MetLife, Inc. (NYSE:MET - Free Report) by 12.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 44,323 shares of the financial services provider's stock after selling 6,534 shares during the quarter. Atria Investments Inc's holdings in MetLife were worth $3,656,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently bought and sold shares of the business. Tompkins Financial Corp raised its position in MetLife by 11.0% in the 3rd quarter. Tompkins Financial Corp now owns 1,904 shares of the financial services provider's stock worth $157,000 after purchasing an additional 188 shares during the period. Assetmark Inc. increased its stake in shares of MetLife by 2.6% in the 3rd quarter. Assetmark Inc. now owns 97,989 shares of the financial services provider's stock worth $8,082,000 after acquiring an additional 2,499 shares in the last quarter. Verdence Capital Advisors LLC increased its holdings in shares of MetLife by 71.2% in the 3rd quarter. Verdence Capital Advisors LLC now owns 9,652 shares of the financial services provider's stock worth $796,000 after purchasing an additional 4,013 shares in the last quarter. SpiderRock Advisors LLC boosted its position in MetLife by 4.6% in the third quarter. SpiderRock Advisors LLC now owns 13,757 shares of the financial services provider's stock worth $1,135,000 after purchasing an additional 603 shares during the last quarter. Finally, Capital Performance Advisors LLP purchased a new position in shares of MetLife during the 3rd quarter valued at $60,000. Institutional investors and hedge funds own 89.81% of the company's stock.
MetLife Stock Performance
NYSE:MET traded up $0.58 during midday trading on Thursday, hitting $82.60. The company's stock had a trading volume of 2,702,770 shares, compared to its average volume of 3,325,849. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The firm has a market cap of $57.19 billion, a P/E ratio of 16.54, a P/E/G ratio of 0.75 and a beta of 1.05. The firm's 50 day moving average is $81.30 and its 200-day moving average is $75.43. MetLife, Inc. has a fifty-two week low of $61.61 and a fifty-two week high of $86.94.
MetLife Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be paid a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.64%. MetLife's dividend payout ratio (DPR) is presently 43.95%.
Analysts Set New Price Targets
MET has been the subject of a number of analyst reports. StockNews.com upgraded MetLife from a "hold" rating to a "buy" rating in a research note on Tuesday. TD Cowen began coverage on MetLife in a research report on Wednesday, October 9th. They set a "buy" rating and a $97.00 price objective for the company. Barclays reduced their price objective on MetLife from $91.00 to $90.00 and set an "overweight" rating for the company in a research note on Thursday, October 31st. Morgan Stanley cut their price target on MetLife from $86.00 to $85.00 and set an "overweight" rating for the company in a report on Monday, August 19th. Finally, Wells Fargo & Company raised their target price on shares of MetLife from $92.00 to $93.00 and gave the company an "overweight" rating in a research note on Tuesday, November 5th. Fourteen research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of $88.46.
Check Out Our Latest Research Report on MetLife
MetLife Company Profile
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.